D.E. Shaw & Co’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9K Sell
30,017
-322,732
-91% -$243K ﹤0.01% 4397
2025
Q4
$310K Buy
352,749
+291,670
+478% +$312K ﹤0.01% 4130
2025
Q3
$83.1K Buy
+61,079
New +$92.5K ﹤0.01% 4369
2025
Q1
Sell
-449,454
Closed -$1.91M 4352
2024
Q4
$1.91M Buy
449,454
+56,527
+14% +$218K ﹤0.01% 2770
2024
Q3
$1.3M Sell
392,927
-112,427
-22% -$382K ﹤0.01% 3071
2024
Q2
$1.56M Buy
505,354
+123,835
+32% +$408K ﹤0.01% 2871
2024
Q1
$1.54M Buy
+381,519
New +$1.44M ﹤0.01% 2811
2023
Q3
Sell
-94,629
Closed -$887K 4298
2023
Q2
$887K Buy
94,629
+72,013
+318% +$632K ﹤0.01% 3158
2023
Q1
$196K Buy
22,616
+2,698
+14% +$23.8K ﹤0.01% 3905
2022
Q4
$141K Sell
19,918
-109,812
-85% -$921K ﹤0.01% 4324
2022
Q3
$1.29M Buy
129,730
+82,865
+177% +$748K ﹤0.01% 3392
2022
Q2
$335K Buy
+46,865
New +$342K ﹤0.01% 4307

Other funds holding DCGO

D.E. Shaw & Co's DCGO Position: Q1 2026 in Review

D.E. Shaw & Co reduced its DocGo (DCGO) stake by 91% in Q1 2026, selling an estimated $243K and leaving 30,017 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4397.

D.E. Shaw & Co first reported a position in DCGO in Q2 2022 and has held it in 12 quarters since. The position peaked at $1.91M in Q4 2024. 122 funds tracked by Wall St. Rank hold DCGO as of Q1 2026.

  • D.E. Shaw & Co held 30,017 shares of DocGo worth $18.9K as of Q1 2026.
  • D.E. Shaw & Co sold 322,732 DocGo shares in Q1 2026, an estimated $243K.
  • DocGo made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4397 holding.
  • D.E. Shaw & Co first reported a position in DocGo in Q2 2022 and has held it in 12 quarters since.
  • D.E. Shaw & Co's DocGo position peaked at $1.91M in Q4 2024.
  • 122 funds tracked by Wall St. Rank held DocGo as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.